RAC 2.20% $1.78 race oncology ltd

Fusion had 'de-risked' itself with it's novel approach to...

  1. 2,338 Posts.
    lightbulb Created with Sketch. 345
    Fusion had 'de-risked' itself with it's novel approach to radiopharmaceuticals and so AstraZeneca came along and the rest is now history. Whilst RAC has all the risks to overcome, it remains a reliable trade if you have the stomach for it - very predictable (at the moment).
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.